Crossmark Global Holdings’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-17,011
| Closed | -$1.29M | – | 1284 |
|
|
2026
Q1 | $1.29M | Sell |
17,011
-252
| -1% | -$18.9K | 0.02% | 531 |
|
|
2025
Q4 | $1.29M | Sell |
17,263
-14,944
| -46% | -$1.09M | 0.02% | 537 |
|
|
2025
Q3 | $2.17M | Buy |
32,207
+16,655
| +107% | +$1.11M | 0.03% | 423 |
|
|
2025
Q2 | $1.01M | Sell |
15,552
-18,585
| -54% | -$1.11M | 0.02% | 604 |
|
|
2025
Q1 | $2.11M | Buy |
34,137
+1,549
| +5% | +$103K | 0.04% | 406 |
|
|
2024
Q4 | $2.35M | Buy |
32,588
+14,487
| +80% | +$1.13M | 0.04% | 359 |
|
|
2024
Q3 | $1.47M | Buy |
18,101
+393
| +2% | +$31.4K | 0.03% | 482 |
|
|
2024
Q2 | $1.31M | Buy |
17,708
+629
| +4% | +$47.1K | 0.03% | 507 |
|
|
2024
Q1 | $1.33M | Buy |
17,079
+56
| +0.3% | +$4.17K | 0.03% | 525 |
|
|
2023
Q4 | $1.22M | Sell |
17,023
-760
| -4% | -$52.9K | 0.03% | 547 |
|
|
2023
Q3 | $1.26M | Sell |
17,783
-22,203
| -56% | -$1.68M | 0.03% | 515 |
|
|
2023
Q2 | $3.23M | Sell |
39,986
-2,822
| -7% | -$231K | 0.07% | 300 |
|
|
2023
Q1 | $3.46M | Sell |
42,808
-2,007
| -4% | -$162K | 0.08% | 273 |
|
|
2022
Q4 | $3.35M | Sell |
44,815
-1,547
| -3% | -$110K | 0.08% | 268 |
|
|
2022
Q3 | $2.99M | Buy |
46,362
+1,285
| +3% | +$89K | 0.08% | 264 |
|
|
2022
Q2 | $3.12M | Buy |
45,077
+1,350
| +3% | +$100K | 0.08% | 272 |
|
|
2022
Q1 | $3.36M | Buy |
43,727
+15,780
| +56% | +$1.13M | 0.07% | 277 |
|
|
2021
Q4 | $2.14M | Buy |
27,947
+10,530
| +60% | +$774K | 0.05% | 387 |
|
|
2021
Q3 | $1.29M | Buy |
17,417
+130
| +0.8% | +$9.75K | 0.03% | 531 |
|
|
2021
Q2 | $1.15M | Sell |
17,287
-500
| -3% | -$33.4K | 0.03% | 565 |
|
|
2021
Q1 | $1.32M | Sell |
17,787
-1,160
| -6% | -$88.1K | 0.03% | 499 |
|
|
2020
Q4 | $1.38M | Sell |
18,947
-1,613
| -8% | -$114K | 0.03% | 474 |
|
|
2020
Q3 | $1.37M | Sell |
20,560
-2,400
| -10% | -$152K | 0.04% | 447 |
|
|
2020
Q2 | $1.31M | Sell |
22,960
-237
| -1% | -$11.6K | 0.04% | 452 |
|
|
2020
Q1 | $814K | Buy |
23,197
+524
| +2% | +$24.9K | 0.03% | 516 |
|
|
2019
Q4 | $1.18M | Buy |
22,673
+80
| +0.4% | +$3.98K | 0.03% | 513 |
|
|
2019
Q3 | $1.14M | Buy |
22,593
+52
| +0.2% | +$2.56K | 0.03% | 501 |
|
|
2019
Q2 | $1.08M | Sell |
22,541
-539
| -2% | -$24.9K | 0.03% | 537 |
|
|
2019
Q1 | $1.12M | Buy |
23,080
+180
| +0.8% | +$8.12K | 0.03% | 526 |
|
|
2018
Q4 | $941K | Sell |
22,900
-22,407
| -49% | -$919K | 0.03% | 542 |
|
|
2018
Q3 | $1.86M | Sell |
45,307
-636
| -1% | -$25.7K | 0.05% | 425 |
|
|
2018
Q2 | $1.83M | Sell |
45,943
-2,290
| -5% | -$88.1K | 0.05% | 419 |
|
|
2018
Q1 | $1.8M | Sell |
48,233
-1,969
| -4% | -$79.6K | 0.05% | 444 |
|
|
2017
Q4 | $2.15M | Buy |
50,202
+15,818
| +46% | +$631K | 0.05% | 404 |
|
|
2017
Q3 | $1.26M | Buy |
+34,384
| New | +$1.39M | 0.03% | 543 |
|
|
2016
Q3 | $1.26M | Buy |
+34,384
| New | +$1.3M | 0.03% | 543 |
|
Other funds holding HOLX
Crossmark Global Holdings's HOLX Position: Q2 2026 in Review
Crossmark Global Holdings sold out of Hologic (HOLX) in Q2 2026, closing a stake of 17,011 shares — an estimated $1.29M sold.
Crossmark Global Holdings first reported a position in HOLX in Q3 2016 and held it in 36 quarters. The position peaked at $3.46M in Q1 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Crossmark Global Holdings reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Crossmark Global Holdings sold 17,011 Hologic shares in Q2 2026, an estimated $1.29M.
- Crossmark Global Holdings first reported a position in Hologic in Q3 2016 and held it in 36 quarters.
- Crossmark Global Holdings's Hologic position peaked at $3.46M in Q1 2023.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.